Analysis of european policy towards generic medicines
In this paper, we provide an overview of a PhD project we undertook on European policy on generic medicines. In the course of our research, we identified various causes for delayed market access of generic medicines and the need for policies to accelerate market access. These should work in conjunction with policies designed to influence demand, as these can significantly affect use of generic medicines. Ideally, demand-side policies should focus on promoting the use of generic medicines to physicians, pharmacists and patients, with or without financial incentives. Lastly, we present our recommendations for increasing the use of generic medicines.
|Keywords||Demand-side policies, Europe, European policy, Generic medicines, Supply-side policies|
|Persistent URL||dx.doi.org/10.5639/gabij.2014.0301.011, hdl.handle.net/1765/95309|
Dylst, P, Vulto, A.G, & Simoens, S. (2014). Analysis of european policy towards generic medicines. GaBI Journal, 3(1), 34–35. doi:10.5639/gabij.2014.0301.011